Skip to main content

Table 2 Multi-drug resistance (MDR)a rates among MRSA from inpatients and outpatients by specimen sourceb

From: Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States

  Inpatient Outpatient
Specimen Source Total N (%) MDR Total N (%) MDR
Lower Respiratory Tract 5,134 (67.8) 1,136 (65.0)
Skin and Soft Tissue 2,122 (35.8) 2,275 (22.2)
Blood 3,064 (63.3) 904 (56.7)
  1. aMultiple-drug resistance (MDR): resistance to three or more of the following agents: ciprofloxacin, erythromycin, clindamycin, gentamicin, trimethoprim/sulfamethoxazole, linezolid, and vancomycin
  2. bCumulative data 1998 – March 2005